← Back to Screener
NeuroSense Therapeutics Ltd. Warrant (NRSNW)
Price$0.19
Momentum ScoreF
Favorite Metrics
Price vs S&P 500 (26W)-103.36%
Price vs S&P 500 (4W)-68.46%
VGM Score2.02
All Metrics
Price vs S&P 500 (YTD)-93.95%
10-Day Avg Trading Volume0.00M
3-Month Avg Trading Volume0.00M
52-Week High$1.00
26-Week Price Return-89.48%
13-Week Price Return-78.97%
3-Month Return Std Dev308.18%
Year-to-Date Return-76.98%
5-Day Price Return-47.43%
Month-to-Date Return-63.18%
Price vs S&P 500 (13W)-87.84%
Beta0.99x
52-Week Low$0.07
mGradeF
vgmGradeF
Show chart for
Industry Peers — Pharmaceuticals(550)
| Symbol | Value Score | Growth Score | Momentum Score | Price |
|---|---|---|---|---|
NRSNWNeuroSense Therapeutics Ltd. Warrant | — | — | F | $0.19 |
| LLYEli Lilly & Co. | D | B | B | $1082.20 |
| JNJJohnson & Johnson | C | C | C | $223.51 |
| ABBVABBVIE INC. | D | C | C | $212.93 |
| MRKMerck & Co., Inc. | C | C | C | $115.17 |
| NVSNovartis AG | C | C | C | $145.68 |
| AZNAstraZeneca PLC | D | B | C | $179.71 |
| NVONovo-Nordisk A/S | B | B | C | $44.07 |
| ABTAbbott Laboratories | C | C | D | $87.78 |
| PFEPfizer Inc. | B | C | C | $25.63 |
| TEVATeva Pharmaceutical Industries Limited American Depositary Shares | C | C | C | $34.64 |
About
NeuroSense Therapeutics is a clinical-stage biotechnology company developing treatments for neurodegenerative diseases including ALS, Alzheimer's, and Parkinson's disease. Its lead product candidate, PrimeC, is an extended-release oral formulation combining two FDA-approved generic drugs in a fixed-dose combination. The company aims to repurpose existing medications to address unmet needs in neurodegenerative disease treatment.